%A Mi,Yajing %A Guo,Na %A Luan,Jing %A Cheng,Jianghong %A Hu,Zhifang %A Jiang,Pengtao %A Jin,Weilin %A Gao,Xingchun %D 2020 %J Frontiers in Immunology %C %F %G English %K MDSC,Glioma,Immunosuppression,Tumor Microenvironment,Therapeutic target %Q %R 10.3389/fimmu.2020.00737 %W %L %M %P %7 %8 2020-April-24 %9 Review %# %! MDSCs and glioma immune suppression %* %< %T The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment %U https://www.frontiersin.org/articles/10.3389/fimmu.2020.00737 %V 11 %0 JOURNAL ARTICLE %@ 1664-3224 %X Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid progenitor and precursor cells at different stages of differentiation, which play an important role in tumor immunosuppression. Glioma is the most common and deadliest primary malignant tumor of the brain, and ample evidence supports key contributions of MDSCs to the immunosuppressive tumor microenvironment, which is a key factor stimulating glioma progression. In this review, we summarize the source and characterization of MDSCs, discuss their immunosuppressive functions, and current approaches that target MDSCs for tumor control. Overall, the review provides insights into the roles of MDSC immunosuppression in the glioma microenvironment and suggests that MDSC control is a powerful cellular therapeutic target for currently incurable glioma tumors.